Literature DB >> 17511568

Cytori Therapeutics, Inc.

Eric Daniels1.   

Abstract

Cytori Therapeutics, Inc. develops stem and regenerative cell therapies that can be used in a 'real-time' treatment setting for cardiovascular disease, reconstructive surgery and many other serious, chronic and life-threatening conditions and disorders. Cytori uses adult stem cells from adipose tissue, which offers a rich, accessible and autologous source of adult stem cells, and maximizes these benefits to create a cost-effective and safe treatment option.

Entities:  

Mesh:

Year:  2007        PMID: 17511568     DOI: 10.2217/17460751.2.3.317

Source DB:  PubMed          Journal:  Regen Med        ISSN: 1746-0751            Impact factor:   3.806


  1 in total

1.  Cell-assisted lipotransfer.

Authors:  Soraya Grabin; Gerd Antes; G Björn Stark; Edith Motschall; Sabine Buroh; Florian M Lampert
Journal:  Dtsch Arztebl Int       Date:  2015-04-10       Impact factor: 5.594

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.